Viking Therapeutics is nearing the finish line with a candidate for weight loss -- to potentially enter a drug market that’s approaching $100 billion. This biotech has candidates in phase 2 and phase ...

Viking (NYSE:VIK) priced its secondary offering of an aggregate of ~30.53M ordinary shares at a public offering price of $44.20 per share. The offering is expected to close on May 29, 2025. The ...

(RTTNews) - Viking Holdings Ltd (VIK) announced the pricing of its secondary offering of an aggregate of about 30.53 million ordinary shares at a public offering price of $44.20 per share. The ...

Subscribe to Marlin magazine and get a year of highly collectible, keepsake editions – plus access to the digital edition and archives. Sign up for the free Marlin email newsletter. This year’s ...

Viking Holdings Ltd. has set terms for its initial public offering, which puts the cruise operator on a heading to be valued at up to $10.8 billion. The Bermuda-based company said 44 million shares ...